Differences and Similarities in Diabetes Research between China and the USA

Hong, Fan; Bhurke, Sheetal; Jia, Guizhen

doi:10.3390/ijerph16162989

Cited by 3 publications

(3 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…China has become the nation with the greatest population of diabetes patients in the world in 2016 when the country's overall number of diabetic patients surpassed 100 million. Additionally, 84.1 million Americans are in pre-diabetes, and 30.3 million are with diabetes [3]. Diabetes prevalence has grown dramatically in low-and middle-income nations, as has the burden of disease, which greatly affected people's healthy lives and had a great impact on human health in all aspects of the world.…”

Section: Introductionmentioning

confidence: 99%

Comparative Analysis of Diabetes in China and The United States-Based on Risky Factor, Complications and Quality of Life

Hu¹,

Shi²,

Wu³

et al. 2023

HSET

View full text Add to dashboard Cite

Of the two main types of diabetes, the most prevalent kind of diabetes is type 2 diabetes (T2D). In many of the world's countries with high diabetes rates and large populations, China and the United States are two nations that can be used as a point of reference when trying to find a solution to the diabetes problem. This paper analyzes the differences between China and the United States in terms of three aspects: risk factors, complications and the quality of life-related to this disease. Obesity is a risk factor that has a significant impact on diabetes in both the United States and in China, and smoking is also one of the risk factors which is more prominent in China. In terms of complications, the complications in the United States and China are almost the same, and the incidence is basically similar. The poor performance of pancreatic beta-cells and the disparity in treatment levels, however, are likely to blame for China's considerably greater prevalence of diabetic complications than the US. In China, the living quality of patients with any kind of diabetes depends more on the patient's economic status and education level, while in the United States, depends on cultural differences. Race is also an important factor affecting patients’ quality of life.

show abstract

Section: Introductionmentioning

confidence: 99%

Comparative Analysis of Diabetes in China and The United States-Based on Risky Factor, Complications and Quality of Life

Hu¹,

Shi²,

Wu³

et al. 2023

HSET

View full text Add to dashboard Cite

show abstract

“…The prevalence of diabetes in China has increased significantly from 0.9% in 1980 to 11.6% in 2010 [1] . By 2016, the total number of diabetes in China has reached 100 million and is still growing steadily [2] . As the country with the largest number of patients in the world, China is facing many problems and challenges.…”

Section: Introductionmentioning

confidence: 99%

Research Progress in the Effect Evaluation of GLP1-1 Agonists

Wang

Liang

2022

JCNR

View full text Add to dashboard Cite

Glucagon-like peptide-1 (GLP-1) promotes insulin secretion, inhibits glucagon secretion, and repairs pancreatic islet cell function to enhance islet cell proliferation and regeneration. Furthermore, it includes a mechanism for weight loss and angiocarpy protection. This study covers the comparison of GLP-1 agonists with DPP-4 inhibitors and GLT-2 inhibitors, the mechanism of GLP-1 agonists, and its research possibilities based on a summary of current clinical tests of GLP-1 receptor agonists.

show abstract

“…Despite a large number of publications on pediatric T1D, a precise estimate of global research output is not available in literature. There are several scientometric analyses conducted on diabetes research in countries with high disease burden such as India, China, European and Middle East countries but all of them are focused on Type 2 diabetes (T2D) [2][3][4][5][6][7][8][9][10]. Only one previous paper has analysed the publication output on T1D from the Middle-East countries [11].…”

Section: Introductionmentioning

confidence: 99%

Pediatric type 1 diabetes research in the 21st century: a scientometric review

Gupta

Dayal²

2020

pedm

View full text Add to dashboard Cite

Introduction: Scientometric studies help scientists to identify research gaps and plan future research. There is no scientometric assessment of research on childhood onset type 1 diabetes (T1D), despite an intensive research in this field over the past 2 decades. Aim of the study: To provide a scientometric assessment of global research output in pediatric T1D. Material and methods: Publications on pediatric T1D indexed in Scopus database over the 20-year period from 2000 to 2019 were examined. The most productive and impactful countries, organizations and authors, trends in research, the media of publications and characteristics of high cited publications were identified using appropriate bibliographic tools. Results: Pediatric T1D research registered 7.84% and 79.99% annual and 10-year cumulative growth and averaged 19.35 citations per paper (CPP). The field witnessed an uneven participation of 141 countries, wherein 82.67% of the global research output share came from top 10 countries. USA leads the ranking with 29.76% share, followed by UK (10.56%), Germany, Italy, Sweden and Australia (5.15% to 7.88%), and Poland, Finland, Canada and Denmark (3.04% to 4.24%). Five countries which registered relative citation index (RCI) higher than their group average of 1.63 were Finland (2.30), UK (1.82), Canada (1.77), Denmark and USA (1.74 each). The number of participating organizations and authors was 3627 and 5596 respectively. Conclusions: The USA and Finland are the most productive and the most impactful countries respectively in global pediatric T1D research. The contribution from developing countries especially from Southeast Asia is meager despite a large disease burden.

show abstract

Differences and Similarities in Diabetes Research between China and the USA

Cited by 3 publications

References 16 publications

Comparative Analysis of Diabetes in China and The United States-Based on Risky Factor, Complications and Quality of Life

Comparative Analysis of Diabetes in China and The United States-Based on Risky Factor, Complications and Quality of Life

Research Progress in the Effect Evaluation of GLP1-1 Agonists

Pediatric type 1 diabetes research in the 21st century: a scientometric review

Contact Info

Product

Resources

About